Use of recombinant factor IX in subjects with haemophilia B undergoing surgery.

Autor: RAGNI, M. V, PASI, K. J, WHITE, G. C, GIANGRANDE, P. L, COURTER, S. G, TUBRIDY, K. L

Publikováno v: Haemophilia; Mar2002, Vol. 8 Issue 2, p91-97, 7p, 4 Charts, 4 Graphs

Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates.

Autor: Roth DA; Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA. droth@caregroup.harvard.edu, Kessler CM, Pasi KJ, Rup B, Courter SG, Tubridy KL

Publikováno v: Blood [Blood] 2001 Dec 15; Vol. 98 (13), pp. 3600-6.